Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6233055 | 1.00 | EGFR (0.76) | EGFRERBB2 | |
| SCHEMBL6233060 | 1.00 | EGFR (0.76) | EGFRERBB2 | |
| Trifluoroacetic Acid SCHEMBL6236834 | 0.97 | EGFR (0.72) | EGFRERBB2 | |
| SCHEMBL6232712 | 0.94 | EGFR (0.76) | EGFRERBB2 | |
| SCHEMBL6232718 | 0.94 | EGFR (0.76) | EGFRERBB2 | |
| SCHEMBL6234210 | 0.94 | EGFR (0.74) | EGFRERBB2 | |
| SCHEMBL6234204 | 0.94 | EGFR (0.74) | EGFRERBB2 | |
| SCHEMBL6234313 | 0.91 | EGFR (0.64) | EGFRERBB2 | |
| SCHEMBL6238295 | 0.91 | EGFR (0.64) | EGFRERBB2 | |
| SCHEMBL6234317 | 0.91 | EGFR (0.64) | EGFRERBB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005007083-A2 | CHEMICAL COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2005-01-27 | — | — | WO | claimed |
| WO-2005009457-A1 | RDP58 COMPOSITIONS AND METHODS FOR INHIBITING VASCULARIZATION OF CELL POPULATIONS | SANGSTAT MEDICAL CORPORATION (US) | 2005-02-03 | — | — | WO | disclosed |
| WO-2005007083-A2 | CHEMICAL COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2005-01-27 | — | — | WO | disclosed |